We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1.

Figure 1. From: A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine.

Incidence of nevirapine resistance mutations at day 10 or week 6 post partum for the 3 study arms in P1032 and for PHPT-2. Resistance identified by sequencing in left panel, oligonucleotide ligation assay and sequencing in right panel. The upper limit of the 95% confidence interval is shown. Missing samples are imputed as having resistance. Abbreviations: d, days; ddI, didanosine; LPV/r, lopinavir and ritonavir; NVP, nevirapine; OLA, oligonucleotide ligation assay; ZDV, zidovudine.

Russell B. Van Dyke, et al. Clin Infect Dis. 2012 January 15;54(2):285-293.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk